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C erebral venous thrombosis (CVT) is an uncommon cause of stroke that mostly affects young adults and children. 1 CVT in older patients may differ in important ways from CVT in the young. In young and middle aged patients, CVT has a female predominance, which is attributed to female hormonal influences such as oral contraceptive use, pregnancy, puerperium, and hormone replacement therapy. 1 We determined the clinical characteristics, risk factors, and outcomes of CVT in older patients in a large international cohort of patients with CVT.
Methods

Study Population
We included adult patients with CVT admitted to 1 of 5 academic hos- 2 Appropriate research permits were received by local investigators at each study center. The data and analytic methods are available to other researchers. Interested researchers can contract the corresponding author.
Statistical Analysis
We compared demographics, clinical manifestations, and outcomes between older (uppermost quartile of the age distribution) and younger (lower 3 quartiles of the age distribution) patients. For clinical outcome, we used the modified Rankin Scale score at last follow-up. For comparison of categorical data, we used a χ 2 or Fisher exact test, and for continuous data, we used a Mann-Whitney U test. We applied multivariate logistic regression analysis to study the association between age and clinical outcome, adjusting for sex, history of cancer, intracerebral hemorrhage, coma, and thrombosis of the deep cerebral venous system.
Results
Within the specified time period, data of 843 adult patients with CVT were available for analysis. The median age was 43 years (interquartile range, 30-55 years). Figure) . After adjustment for confounding variables, the risk of poor outcome (modified Rankin Scale, 3-6) was increased in patients aged ≥55 years (adjusted odds ratio, 2.68; 95% confidence interval, 1.78-4.03; Table 2 ). The risk of mortality was also higher in older patients (adjusted odds ratio, 2.13; 95% confidence interval, 1.09-4.19). Further stratification by age groups showed that the outcome was worse with increasing age strata ( Table I in the online-only Data Supplement). 
Background and
Discussion
We found that CVT was equally prevalent in older men and women. Our data substantiate the hypothesis that the overrepresentation of women among patients with CVT in general is explained by female hormonal influences. 3, 4 One in 4 patients with CVT who were >55 years had a history of cancer, making this one of the most common risk factors in this age group. Cancer is a well-known risk factor for more common locations of venous thrombosis, such as deep vein thrombosis of the leg and pulmonary embolism. 5 Cohort studies suggest that, overall, ≈7% of adult patients with CVT have a history of cancer. 6, 7 Unfortunately, our data cannot be used to determine the (cost)-effectiveness of screening for cancer in older patients with CVT because the frequency of diagnosis of cancer at follow-up was not systematically recorded. Nevertheless, given the high prevalence, it seems appropriate to have a low threshold to search for the most common types of cancer in older patients with CVT. The only previous study on CVT in older patients is a post hoc analysis of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis). 8 Our results are mainly concordant with this study. In both studies, CVT was equally prevalent in older men and older women, and headache was less common in older. This latter information is valuable to clinicians because it shows that the possibility of CVT should not be disregarded in the absence of headache in this age group. Mortality was substantially higher in ISCVT (27% versus 13%). In part, this might be explained by a more stringent elderly definition (>65 years) in ISCVT. In addition, improvements in management of patients with CVT, especially decompressive surgery, may have led to a lower mortality rate in our study. 9, 10 Finally, there is an overall trend over time of declining mortality in CVT. 6, 11 A strength of our study is the large number of older CVT patients (51 in ISCVT versus 202 in our study). Useful information on hormonal influence is added by a postmenopausal age cutoff of 55 years. A weaknesses is that baseline modified Rankin Scale score and withdrawal of care information, which may differed between older and younger patients, were not available. In summary, CVT has a divergent clinical profile in older patients. Female predominance is absent in this age group, and ≈1 in 4 patients harbors an underlying malignancy. The prognosis of older CVT patients is worse than younger patients but better than previously characterized. 
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